Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06619327 · ClinicalTrials.gov registry record · NA

Resilient Together for Dementia (RT-D)

A NA study of Dementia, sponsored by Icahn School of Medicine at Mount Sinai.

Recruiting
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT06619327 is a NA study of Dementia that is actively recruiting participants, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 50 participants, below the 7,723-participant average among 199 other Dementia trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06619327, a NA study of Dementia, is actively recruiting participants, sponsored by Icahn School of Medicine at Mount Sinai.

RECRUITING
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

This study will evaluate the feasibility and preliminary efficacy of the novel Resilient Together for Dementia (RT-D) intervention for couples following dementia diagnoses. The primary target is emotional distress, and the program aims to prevent chronic distress in at-risk couples.

Conditions Studied

Dementia

Interventions

  • BEHAVIORAL Resilient Together for Dementia
  • BEHAVIORAL MEUC

Study Locations (1)

New York

  • Brain Injury Research Center at Mount Sinai - New York

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2025-02-19
Est. Completion 2027-06-30
Phase NA

Sponsor

Icahn School of Medicine at Mount Sinai

708 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06619327

The ClinicalTrials.gov registry entry for NCT06619327 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 7,723-participant average among 199 other Dementia trials with a reported enrollment target (99% lower). The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Dementia appearing as the primary indexed condition, and to 2 interventions - of which Resilient Together for Dementia is the first listed.

NCT06619327 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT06619327 about?

NCT06619327 is a clinical study titled "Resilient Together for Dementia (RT-D)". This study will evaluate the feasibility and preliminary efficacy of the novel Resilient Together for Dementia (RT-D) intervention for couples following dementia diagnoses. The primary target is emotional distress, and the program aims to prevent chronic distress in at-risk couples.

What is the current status of trial NCT06619327?

This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2025-02-19. Estimated completion is 2027-06-30.

What conditions does trial NCT06619327 study?

This clinical trial studies the following conditions: Dementia.

What interventions are being tested in trial NCT06619327?

The interventions under investigation include: Resilient Together for Dementia (BEHAVIORAL), MEUC (BEHAVIORAL).

Who is sponsoring clinical trial NCT06619327?

This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06619327 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Dementia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Dementia

All registered trials for this condition

New York

All trials with a study site in New York

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.